https://scholars.lib.ntu.edu.tw/handle/123456789/384391
標題: | A novel PPARgamma agonist monascin's potential application in diabetes prevention | 作者: | TZU-MING PAN | 公開日期: | 2014 | 卷: | 5 | 期: | 7 | 起(迄)頁: | 1334-1340 | 來源出版物: | Food and Function | 摘要: | Edible fungi of the Monascus species have been used as traditional Chinese medicine in eastern Asia for several centuries. Monascus-fermented products possess a number of functional secondary metabolites, including the anti-inflammatory pigments monascin and ankaflavin. Monascin has been shown to prevent or ameliorate several conditions, including hypercholesterolemia, hyperlipidemia, diabetes, and obesity. Recently, monascin has been shown to improve hyperglycemia, attenuate oxidative stress, inhibit insulin resistance, and suppress inflammatory cytokine production. In our recent study, we have found that monascin is a peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist. The PPARgamma agonist activity had been investigated and its exerted benefits are inhibition of inflammation in methylglyoxal (MG)-treated rats, prevention of pancreas impairment causing advanced glycation endproducts (AGEs), promotion of insulin expression in vivo and in vitro, and attenuated carboxymethyllysine (CML)-induced hepatic stellate cell (HSC) activation in the past several years. Moreover, our studies also demonstrated that monascin also activated nuclear factor-erythroid 2-related factor 2 (Nrf2) in pancreatic RIN-m5F cell line thereby invading methylglyoxal induced pancreas dysfunction. In this review, we focus on the chemo-preventive properties of monascin against metabolic syndrome through PPARgamma and Nrf2 pathways. This journal is ? the Partner Organisations 2014. |
URI: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84903276524&partnerID=MN8TOARS http://scholars.lib.ntu.edu.tw/handle/123456789/384391 |
DOI: | 10.1039/c3fo60575b | SDG/關鍵字: | Cell culture; Advanced glycation end products; Cytokine production; Hepatic stellate cells; Hypercholesterolemia; Insulin expressions; Monascus-fermented products; Secondary metabolites; Traditional Chinese Medicine; Insulin; advanced glycation end product; ankaflavin; antidiabetic agent; antiinflammatory agent; antioxidant; fused heterocyclic rings; insulin; monascin; Nfe2l2 protein, rat; peroxisome proliferator activated receptor gamma; riboflavin derivative; transcription factor Nrf2; agonists; animal; chemistry; cytology; diabetes mellitus; drug effects; human; liver; metabolism; Monascus; pancreas; rat; Animals; Anti-Inflammatory Agents; Antioxidants; Diabetes Mellitus; Flavins; Glycosylation End Products, Advanced; Heterocyclic Compounds, 3-Ring; Humans; Hypoglycemic Agents; Insulin; Liver; Monascus; NF-E2-Related Factor 2; Pancreas; PPAR gamma; Rats |
顯示於: | 生化科技學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。